Dr. Engelhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
University of North Carolina HospitalsResidency, Internal Medicine, 2000 - 2003
Case Western Reserve University School of MedicineClass of 2000
Certifications & Licensure
TN State Medical License 2006 - 2026
AL State Medical License 2020 - 2020
NC State Medical License 2000 - 2008- American Board of Internal Medicine Hematology
Clinical Trials
- The Treatment of Hematologic Malignancies With Single or Double Umbilical Cord Blood Unit Transplantation Followed by Graft-Versus-Host Disease Prophylaxis With Tacrolimus and Mycophenolate Mofetil Start of enrollment: 2005 Sep 01
- Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil Start of enrollment: 2005 Sep 01
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsApixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.Robert F. Cornell, Samuel Z. Goldhaber, Brian G. Engelhardt, Javid Moslehi, Madan Jagasia
Frontiers in Oncology. 2019-02-26 - 114 citationsProspective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.Robert F. Cornell, Bonnie Ky, Brendan M. Weiss, Cherie N. Dahm, Deepak K. Gupta
Journal of Clinical Oncology. 2019-06-12 - 51 citationsClassic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).Madan Jagasia, Bipin N. Savani, George P. Stricklin, Brian G. Engelhardt, Adetola A. Kassim
Biology of Blood and Marrow Transplantation. 2009-10-01
Press Mentions
Post-Transplant Diabetes May Be ReversibleFebruary 21st, 2020
Research Explores Link Between Stem Cell Transplant, DiabetesJanuary 17th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
